Any current/future new fundraising through debt or equity?

There is no explicit mention of any current or future fundraising plans through debt or equity in the provided transcript. The company is undergoing a demerger creating two entities: one focusing on the chemical business (insoluble sulphur) and another as an investment company. The investment company will focus on private equity and venture capital investments rather than listed equity. The chemical business will focus on operations and pay out dividends, targeting 50% of PAT as dividend payout. The Board will decide asset allocation and cash movements between the two companies before the deme

Any current/future capex/capital investment/strategic investment?

Phase one of the Insoluble Sulphur (IS) plant (5,500 MT p.a.) was commissioned in December 2021; total IS capacity ~40,000 MT p.a. (Page 3). Additional sulphuric acid plant capacity of 50,000 MT p.a. commissioned at Dharuhera (Page 3). Ramp-up of new capacity expected to take a few quarters (Page 3). Expansion plans ongoing, more utilization anticipated by Q4 FY2023 (Page 13). Post-demerger, the insoluble sulphur (chemical) company will focus on growth, paying ~50% PAT as dividend; retained earnings will be used for related business growth or dividend payout (Page 10). Investment company will

Future growth expectations in sales/revenue/volumes?

Slight increase in sales volumes noted over the previous year. Total income growth was moderate (4% YoY in Q4 FY2022). Demand initially impacted by COVID third wave and geopolitical issues but positive sequential growth expected in Q1 FY2023 compared to Q4 FY2022. Price increases taken to offset rising raw material and freight costs. Phase one capacity expansion (5,500 MT) commissioned in Dec 2021, with total insoluble sulphur capacity at ~40,000 MT per annum. Ramp-up of new capacity expected to take a few quarters, with utilization projected to start gradually by Q4 FY2023. Overall growth exp

Future growth expectations in earnings/operating earnings/profits/EPS?

The company expects demand for commercial vehicles to remain favorable, supporting growth in the insoluble sulphur business. Capacity expansions have been completed, which will aid in gaining new orders and increasing wallet share. Price increases have been implemented to offset rising raw material and freight costs; further price hikes are planned in upcoming quarters. Despite recent inflationary pressures, management believes current challenges are short-term and will taper down. The ramp-up of the newly commissioned 5,500 MT insoluble sulphur plant (part of total 40,000 MT capacity) will ta

Current/ Expected Orderbook/ Pending Orders?

The transcript does not provide specific figures or detailed information on the current or expected order book/pending orders for Oriental Carbon and Chemicals Limited. However, the company expressed confidence in gaining new orders and increasing wallet share following the completion of capacity expansions. The company mentioned a positive outlook supported by phased capacity ramp-ups, including the commissioning of a new insoluble sulphur plant and an additional sulphuric acid plant. Demand was impacted initially due to external factors like COVID waves and geopolitical issues, but recent in

AG Ventures LtdQ4 FY22Chemicals & Petrochemicals

AG Ventures Ltd Q4 FY22 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹129.2P/E: 5.7Market Cap: ₹128 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

Slight increase in sales volumes noted over the previous year.
Total income growth was moderate (4% YoY in Q4 FY2022).
Demand initially impacted by COVID third wave and geopolitical issues but positive sequential growth expected in Q1 FY2023 compared to Q4 FY2022.
Price increases taken to offset rising raw material and freight costs.
Phase one capacity expansion (5,500 MT) commissioned in Dec 2021, with total insoluble sulphur capacity at ~40,000 MT per annum.
Ramp-up of new capacity expected to take a few quarters, with utilization projected to start gradually by Q4 FY2023.
Overall growth expected from increased capacity, new orders, and improved wallet share.
Management confident that current external challenges and input cost pressures are short-term and will taper down soon.

Margin guidance

Category 3

The company expects demand for commercial vehicles to remain favorable, supporting growth in the insoluble sulphur business.
Capacity expansions have been completed, which will aid in gaining new orders and increasing wallet share.
Price increases have been implemented to offset rising raw material and freight costs; further price hikes are planned in upcoming quarters.
Despite recent inflationary pressures, management believes current challenges are short-term and will taper down.
The ramp-up of the newly commissioned 5,500 MT insoluble sulphur plant (part of total 40,000 MT capacity) will take a few quarters, indicating volume growth ahead.
Dividend payout policy targets 50% of PAT as dividends, signaling strong free cash flow generation.
Outlook includes focus on chemical business growth while investment business operates separately post-demerger.
Overall confidence expressed in expanding capacity and improving financials as external challenges ease.

See what AG Ventures Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no explicit mention of any current or future fundraising plans through debt or equity in the provided transcript.
The company is undergoing a demerger creating two entities: one focusing on the chemical business (insoluble sulphur) and another as an investment company.
The investment company will focus on private equity and venture capital investments rather than listed equity.
The chemical business will focus on operations and pay out dividends, targeting 50% of PAT as dividend payout.
The Board will decide asset allocation and cash movements between the two companies before the demerger.
No specific plan for raising new debt or equity has been disclosed during this call.

Order book

The transcript does not provide specific figures or detailed information on the current or expected order book/pending orders for Oriental Carbon and Chemicals Limited.
However, the company expressed confidence in gaining new orders and increasing wallet share following the completion of capacity expansions.
The company mentioned a positive outlook supported by phased capacity ramp-ups, including the commissioning of a new insoluble sulphur plant and an additional sulphuric acid plant.
Demand was impacted initially due to external factors like COVID waves and geopolitical issues, but recent indications are positive for growth.
No explicit quantitative data on order book size or pending orders was disclosed in the provided pages of the transcript.

See what AG Ventures Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Phase one of the Insoluble Sulphur (IS) plant (5,500 MT p.a.) was commissioned in December 2021; total IS capacity ~40,000 MT p.a. (Page 3).
Additional sulphuric acid plant capacity of 50,000 MT p.a. commissioned at Dharuhera (Page 3).
Ramp-up of new capacity expected to take a few quarters (Page 3).
Expansion plans ongoing, more utilization anticipated by Q4 FY2023 (Page 13).
Post-demerger, the insoluble sulphur (chemical) company will focus on growth, paying ~50% PAT as dividend; retained earnings will be used for related business growth or dividend payout (Page 10).
Investment company will pursue specialized investments primarily in private equity and venture capital (both direct and fund investments) with 20-25% of net worth as a target allocation (Pages 15-16).
Future investments by investment company are under evaluation and could evolve over time (Page 6).

Track AG Ventures Ltd — get its next earnings analysis in your feed

How does AG Ventures Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisAG Ventures Ltd

Rev 4Mar 3

See where AG Ventures Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does AG Ventures Ltd rank in Chemicals & Petrochemicals?

Compare AG Ventures Ltd against every Chemicals & Petrochemicals company (Q4 FY22) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What AG Ventures Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Neogen Chemicals Ltd (Q2 FY27)
Consolidated: ₹295.96 crore (up from ₹208.66 crore in Q3 FY25) . Key results statement takeaways from Neogen Chemicals Ltd's Q2 FY27 results statement — and how
Mahickra Chemicals Ltd (Q2 FY27)
682 million, a 34% year-on-year increase. Key results statement takeaways from Mahickra Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec
Vishnu Chemicals Ltd (Q2 FY27)
2,837.7 lakhs increase (~7.07% growth YoY). Key results statement takeaways from Vishnu Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec
Yasons Chemex (Q2 FY27)
4,927.35 lakhs for the same period in 2025, indicating a year-on-year decline of about 16.3% (Page 12). Key results statement takeaways from Yasons Chemex Care

Compare:vs Solar Industries vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →